Top Fully Remote Biotech Companies (30)
At Inato, we’re on a mission to accelerate the pace of medical innovation by bringing clinical research to each and every patient, regardless of who they are and where they live. Our platform, made to connect community-based research centers to trials across the globe, aims to create greater visibility, access, and engagement across a more diverse population of doctors and their patients.
Aster Insights is a health informatics solutions company focused on accelerating the discovery, development, and delivery of personalized medicine. The company runs one the world’s largest observational research studies in cancer, which tracks patients throughout their lifetime, links longitudinal clinical data with molecular information, and enables a deeper understanding of a patient’s disease. Aster Insights has established one of the largest and most comprehensive linked clinical and genomic databases in the country, empowering innovative, collaborative cancer research and supporting the development of novel oncology drugs by its biopharmaceutical partners. Aster Insight’s data platform includes more than 400,000 patients across its alliance of leading cancer research centers, known as the Oncology Research Information Exchange Network (ORIEN). ORIEN members benefit through collaborative research and shared data; Aster Insight's biopharmaceutical partners benefit through access to the network and a dataset that supports clinical trial design, patient recruiting and new therapy development; and the ultimate beneficiaries are patients, as this process informs new drug treatment options. Indeed, Aster Insight’s data asset is unique in the market – and to date not widely known. Patient consent, as this brief explains, also gives it a significant competitive advantage to others emerging in this space. In December 2021, Aster Insights announced a formative collaboration with Microsoft to “to develop next generation data-driven solutions for oncology
Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate, FT218, is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. At Avadel, our core values foster an atmosphere of innovation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development and delivery of medicines that will transform the treatment landscape and have the greatest impact on people living with narcolepsy. Learn more about us at www.avadel.com and follow us on Twitter at @AvadelPharma.
Vow is a cultured meat company, founded and operated in Sydney, Australia. We’re a multidisciplinary team of scientists, technologists and designers, all working together to make sustainable food both irresistible and available to billions of people.
Ringtail Labs is a full-stack engineering consulting firm. We help teams launch new products, fix issues in their existing products, and build a positive engineering culture. Our services include circuit board design, embedded software/firmware, cloud infrastructure and DevOps, and web application development.
BioReact leverages the power of artificial intelligence and machine learning to help with design of experiment (DOE) and optimizing the parameters to help your cells reach their full potential.
We are a group of engineers and innovators, working together to create and launch ingenious products and companies today for a sustainable tomorrow. Our vision is to paradigm shift R&D in the country, making it a competitive driver in the transformation of the national economy. With a mission to seed intellectual potential for a sustainable future, eiGroup embraces an integrated approach to research, development, and innovations that results in practical change across education and industries
Normunity, Inc., is a biotechnology company creating a new class of precision immuno-oncology medicines, called immune normalizers, that target novel mechanisms that free the body’s normal immunity against cancer. Based on an ongoing, interactive academic-biotech alliance with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is targeting newly-discovered mechanisms of immune disruption in cancer based on proprietary discovery platforms that elucidate the complex interactions between human cancer and the immune system. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer. Normunity is located in Boston, Mass. and West Haven, Conn
RegFront is building technology to improve the speed, quality, and consistency of drug development to help bring life-changing treatments to market more effectively. The global drug R&D market spends tens of billions of dollars annually with consistently decreasing returns on investment. There are countless factors, but the one we’re addressing first is the inefficiencies in managing the regulatory process - communication with regulatory agencies like the FDA and developing strategies based on regulatory requirements.
Michal Morrison, Inc. is a science-first skincare company established in stem cell science, supported by our patented βSTEM6 molecule. A biotech breakthrough, βSTEM6 is a proprietary metamolecule that restores the self- rejuvenating power of the skin that has diminished over time. The molecule works with the skin's stem cells to rejuvenate the appearance of aging skin. With this patented technology, Michal Morrison, Inc. is leading a new category of biomimetic skincare.
BioNews is a health media company focused on rare diseases and rare patient experiences. BioNews provides an insider’s view into disease and treatment news, condition management information, and community across more than 60+ diseases and brands. A fierce champion of the rare voice, BioNews brands are designed to reach, engage, and elevate even the smallest patient populations. We’re the only rare news and information property in the U.S. and are committed to the insider’s view into a rare disease or experience. People turn to our brands for timely treatment news, management, and community.
AllStripes’ mission is to unlock new treatments for people with rare disease. About 1 in 10 people have a rare disease, and half are children. AllStripes (formerly RDMD) was co-founded in 2017 by CEO Nancy Yu and Onno Faber, a rare disease patient deeply frustrated by the drug development process. “I was diagnosed with a rare genetic disease and it completely changed my perspective,” Onno shares. “Patients can’t be bystanders in drug development.” As the first and only research platform dedicated to rare diseases, AllStripes makes it easy for patients to contribute to new treatment studies from home. We do the work to collect and analyze your de-identified medical records to help power faster, better drug development for your condition. The name AllStripes was inspired by the official symbol for the rare disease community, the zebra. When we come together and learn from each other’s experiences we can push for better treatments across all rare conditions.
ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products. With a deep and global network, ArriVent seeks to access unique and best-in-class drug candidates at various development stages, including those coming from China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, ArriVent aims to globalize medicines for patients with unmet medical need in a broad range of diseases, with an initial focus in oncology.
Hi Fidelity Genetics is a computational biology company aiming to change the productivity of global agriculture
Motitus is a consulting firm specializing in biotechnology, pharmaceuticals, healthcare, life sciences, and health tech, working with ambitious leaders. We bridge the gap between thinking and implementation with extraordinary impact. We deliver mission projects that transform your business into state-of-the-art for the industry. The word Motitus carries a compelling narrative that resonates deeply within the realms of healthcare and innovation. The name itself, derived from the Latin word for "movement," encapsulates the essence of progress, dynamism, and transformation—qualities that are vital in the fast-evolving landscape of health and medicine. From its inception, Motitus aimed to be more than just a consultancy; it sought to be a catalyst for change. The brand's identity is built around the concept of movement, representing the fluidity and adaptability required in modern healthcare. Whether it’s helping a pharmaceutical company navigate regulatory hurdles or assisting a biotech startup in bringing its product to market, Motitus embodies the spirit of progress and agility.
arivis is a specialized biomedical big image data and compliance software company in the life science industry. Its revolutionary, award winning software enables users to visualize, analyze, distribute and to manage even multi-terabyte multi-dimensional (2D, 3D, 4D, 5D, 6D) image datasets that are e.g. created by microscopes or scanners, very fast, efficient – and on ordinary PCs and laptops! Moreover arivis solutions help customers to meet the world-wide ever-increasing regulatory, quality and compliance requirements in research, clinical trials, approval, and maintenance of medical devices and medicinal products. a
Parachute is a new kind of plasma donation company that allows individuals to earn money while creating life-saving medicine. Plasma is used to create medicine that treats chronic illnesses, including immune disorders, liver disease, bleeding disorders, and cancer. Right now, there’s a severe plasma shortage, which is impacting patients’ access to these life-saving treatments
In vitro diagnostic company, specializing in the production of antibodies, controls, blockers including HBR. - Clean Rooms - Filling - Finishing - Packaging - Sub-Assembly - Inventory Space - Kit Manufacturing - Lyophilization - Antibody Production - Medical Device Manufacturing
Our Mission Our mission is to unite biopharma, physicians, and patients to transform the standard of care and improve outcomes with personalized diagnostics. Our Vision We envision a world where all critical diseases are diagnosed early and treated quickly with the guidance of personalized diagnostic solutions, so humanity can thrive without the burden of disease.
Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.
Work Your Passion. Live Your Purpose.
